Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

It remains controversial whether busulfan-based versus total body irradiation (TBI)–based regimens have comparable outcomes in patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic hematopoietic stem-cell transplantation (allo-HSCT). We investigated the efficacy and toxicity of busu...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Haiyan, Fan, Zhiping, Huang, Fen, Han, Lijie, Xu, Yajing, Xu, Na, Deng, Lan, Wang, Shunqing, Lin, Dongjun, Luo, Xiaodan, Zhang, Qing, Liu, Xiaodan, Li, Xudong, Liang, Xinquan, Xie, Shuangfeng, Qu, Hong, Yu, Sijian, Zhou, Hongsheng, Shi, Pengcheng, Xuan, Li, Lin, Ren, Liu, Hui, Jin, Hua, Sun, Jing, Liu, Qifa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839269/
https://www.ncbi.nlm.nih.gov/pubmed/36084276
http://dx.doi.org/10.1200/JCO.22.00767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9839269/
https://www.ncbi.nlm.nih.gov/pubmed/36084276
http://dx.doi.org/10.1200/JCO.22.00767

Ejemplares similares